Drugs / lactobacillus delbruekii
last change Feb 2020 re-read 2 minutes ago

lactobacillus delbruekii

Developed for
irritable bowel syndrome

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
NCT04572932 Comparator May → Dec 2019 irritable bowel syndrome Ain Shams University Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as lactobacillus delbruekii ClinicalTrials.gov intervention name — accepted as the source's own label NCT04572932